{"nct_id":"NCT02628574","title":"Phase 1 Open-label Study of TRX518 Monotherapy and TRX518 in Combination With Gemcitabine, Pembrolizumab, or Nivolumab","status":"COMPLETED","status_verified_date":"2025-07","start_date":"2016-01","start_date_type":"ACTUAL","primary_completion_date":"2020-07-14","primary_completion_date_type":"ACTUAL","completion_date":"2020-07-14","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["LPTX"]}